Ozempic Approved for Obesity and Heart Disease Treatment in Australia

Ozempic has been endorsed for treating obesity and heart disease in Australia, marking a significant advancement in healthcare. With two-thirds of Australians at risk of cardiovascular disease, this GLP-1 medication offers a potential solution to combat these health issues. The endorsement represents a major step forward in addressing obesity-related conditions.

Read the full story at SBS News→